Financial Perspectives, Inc
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2003287
MINNEAPOLIS, MN
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$119,096
-$28,478 QoQ
Shares Held
191
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,079
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $866,211 across 15 Biotechnology names. REGN ranks #5 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
588 | $167,562 | |
| 2 | ARGX |
Argenx SE
|
145 | $134,526 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
2,422 | $132,095 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,155 | $120,830 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
191 | $119,096 | |
| 6 | INCY |
Incyte Corp
|
1,000 | $113,360 | |
| 7 | GMAB |
Genmab A/S
|
1,333 | $36,617 | |
| 8 | MRNA |
Moderna, Inc.
|
230 | $16,106 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,096 | 191 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $147,574 | 191 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $148,970 | 193 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $108,518 | 193 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $101,325 | 193 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $122,406 | 193 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $137,479 | 193 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $182,915 | 174 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $182,879 | 174 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $167,473 | 174 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $152,822 | 174 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $143,195 | 174 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $125,025 | 174 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $142,970 | 174 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $125,539 | 174 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $119,863 | 174 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $102,856 | 174 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $121,525 | 174 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $109,884 | 174 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $105,301 | 174 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $97,185 | 174 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $174 | 82,326 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $84,061 | 174 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $44,782 | 80 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $42,408 | 68 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $33,203 | 68 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||